Bicara Therapeutics Inc.
Company Stats
- Market Cap
- $1.2B
- as of Sep 30, 2026
- Shares Outstanding
- 66.2M
- Free Float
- 52.9%
Income Statement
- Operating Income
- -$155.6M
- Net Income
- -$137.9M
- EBITDA
- -$155.5M
Cash Flow
- Free Cash Flow
- -$107.1M
- FCF Yield
- -8.7%
- Owner FCF Yield
- -9.9%
Balance Sheet
- Cash & Equivalents
- $96.7M
Returns & Capital
- SBC, 3Y Avg
- $8.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$107.1M | — |
| FY2024 | — | -$74.8M | — |
| FY2023 | — | -$46.2M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 6, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges